Valproate in Late Life Schizophrenia

• Status: Completed
• Trial end date: 2006-11-01

Summary

The purpose of this research study is to analyze the effectiveness and tolerability of a medication, valproate ( Depakote and Depakote ER), in individuals age 50 years and older who have schizophrenia.

• Phase: Phase 4

Details

• Lead Sponsor: University Hospitals Cleveland Medical Center
• Collaborator: Abbott
• Treatments: Valproic Acid